Table 2.
Expanding the scope of glycosylation with SInR donors: synthesis of disaccharides 18–32.Yields and product ratios are invisible in the PDF file for all entries with the figure
| ||
|---|---|---|
| Entry | Donor+Acceptor, amount of NIS, time | Product (Yield, α/β ratio) |
| 1 | 2 (SInMe) + 15, NIS (4.0 equiv), 45 min |
|
| 2 | 2 + 16, NIS (4.0 equiv), 45 min |
|
| 3 | 2 + 17, NIS (4.0 equiv), 15 min |
|
| 4 | 5 (SInMe) +13, NIS (4.0 equiv), 10 min |
|
| 5 | 5 + 13, NIS (3.0 equiv), 20 min | 21 (83%, 1.1/1) |
| 6 | 5 +15, NIS (4.0 equiv), 15 min |
|
| 7 | 5 + 16, NIS (4.0 equiv), 15 min |
|
| 8 | 5 + 17, NIS (4.0 equiv), 15 min |
|
| 9 | 6 (SInAll) +15, NIS (3.5 equiv), 3 h | 18 (68%, β only) |
| 10 | 6 + 16, NIS (3.5 equiv), 1 h | 19 (75%, β only) |
| 11 | 6 + 17, NIS (3.5 equiv), 45 min | 20 (87%, β only) |
| 12 | 8 (SInMe) +13, NIS (3.2 equiv), 10 min | 21 (84%, 1.3/1) |
| 13 | 8 + 15, NIS (3.2 equiv), 20 min | 22 (75%, 1/1.3) |
| 14 | 8 + 16, NIS (3.2 equiv), 10 min | 23 (76%, 1.1/1) |
| 15 | 8 + 17, NIS (3.2 equiv), 10 min | 24 (83%, 1.5/1) |
| 16 | 10 (SInAll) + 13, NIS (3.2 equiv), 1h |
|
| 17 | 10 + 15, NIS (3.5 equiv), 1 h |
|
| 18 | 10 + 16, NIS (3.5 equiv), 1 h |
|
| 19 | 10 + 17, NIS (3.5 equiv), 1 h |
|
| 20 | 12 (SInAll) +13, NIS (3.2 equiv), 1.5 h |
|
| 21 | 12 + 15, NIS (3.5 equiv), 2.5 h |
|
| 22 | 12 + 16, NIS (4.0 equiv), 2.5 h |
|
| 23 | 12 + 17, NIS (3.5 equiv), 2.5 h |
|